Prolonged QTc intervals in medicated patients with schizophrenia

Human Psychopharmacology

Volumn 18, Issue 8, 2003, Pages 647-649

  Chong, Siow Ann ^a   Mythily, A ^a   Lum, Alvin ^b   Goh, Hern Yee ^a   Chan, Yiong Huak ^c  

^a INSTITUTE OF MENTAL HEALTH   (Singapore)

^b Shenton Medical Group   (Singapore)

^c Clinical Trials and Epidemiology Research Unit   (Singapore)

Author keywords

Antipsychotics; QTc interval; Schizophrenia; Torsades de pointes

Indexed keywords

CARBAMAZEPINE; CHLORPROMAZINE; FLUPENTIXOL DECANOATE; FLUPHENAZINE DECANOATE; HALOPERIDOL; LITHIUM DERIVATIVE; PSYCHOTROPIC AGENT; THIORIDAZINE; TRIFLUOPERAZINE; ZUCLOPENTHIXOL DECANOATE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; INFORMATION PROCESSING; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PREDICTION; PRIORITY JOURNAL; QT PROLONGATION; RISK FACTOR; SCHIZOPHRENIA; VOLUNTEER;

AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; LONG QT SYNDROME; MALE; RISK FACTORS; SCHIZOPHRENIA; SEX FACTORS;

EID: 0346969635     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.540     Document Type: Article

References (9)

1. Algra A, Tijssen J, Roelandt JR, Pool J, Lubsen J. 1991. QTc prolongation measured by standard 12 lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest. Circulation 83: 1888-1894.
2. Atkins M, Burgess A, Bottomley C, Riccio M. 1997. Chlorpromazine equivalents: a consensus of opinion for both clinical and research applications. Psychiatr Bull 21: 224-226.
3. Buckley NA, Sanders P. 2000. Cardiovascular adverse effects of antipsychotic drugs. Drug Saf 23: 215-228.
4. Glassman AH, Bigger JT. 2001. Antipsychotic drugs: prolonged QTc interval, torsades de pointes, and sudden death. Am J Psychiatry 158: 1774-1782.
5. Newman SC, Bland RC. 1991. Mortality in a cohort of patients with schizophrenia: a record linkage study. Can J Psychiatry 36: 239-245.
6. Reilly JG, Ayis SA, Ferrier IN, Jones SJ, Thomas SHL. 2000. QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet 355: 1048-1052.
7. Rey M-J, Schultz P, Costa C, Dick P, Tissot R. 1989. Guidelines for the dosage of neuroleptics: I. Chlorpromazine equivalents of orally administered neuroleptics. Int Clin Psychopharmacol 4: 95-104.
8. Thomas SH. 1994. Drugs, QT interval abnormalities and ventricular arrhythmias. Adverse Drug React Toxicol Rev 13: 77-102.
9. Warner JP, Barnes TRE, Henry JA. 1996. Electrocardiographic changes in patients receiving neuroleptic medication. Acta Psychiatr Scand 93: 311-313.